SCHEMBL13722121

SCHEMBL13722121

CNCCC(C)SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24014940 0.84
SCHEMBL24897657 0.78
SCHEMBL15787947 0.71
SCHEMBL22137871 0.70 EPHX1 (0.32)
SCHEMBL388479 0.69
SCHEMBL21591959 0.69 HTR2A (0.40)
SCHEMBL20675889 0.69
SCHEMBL11922799 0.69 TSHR (0.44)
SCHEMBL7962608 0.67
Hydrochloric Acid SCHEMBL3819655 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230062022-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC (US) 2023-03-02 US disclosed
EP-1463529-B1 PH-SENSITIVE POLYMERIC CONJUGATES OF AN ANTHRACYCLINE CANCEROSTATIC DRUG FOR TARGETED THERAPY ZENTIVA KS (CZ) 2009-08-19 EP disclosed
EP-1782833-A2 pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy ZENTIVA, A.S. (CZ) 2007-05-09 EP disclosed